Characteristic | Mean (SD) or median (Q1–Q3)/N (%) | P-value | |
---|---|---|---|
Prior antiplatelet | mRS ≤ 2 (n = 9) | mRS > 2 (n = 22) | |
Age | 65.33 ± 10.25 | 73.05 ± 8.20 | 0.035 |
HS.CRP | 2.32 (1.16–5.38) | 8.32 (6.80–18.35) | < 0.001 |
Creatinine | 60.01 ± 14.59 | 77.98 ± 21.33 | 0.029 |
Uric acid | 297.63 ± 75.04 | 288.79 ± 75.33 | 0.768 |
Platelet count | 180.22 ± 55.86 | 160.50 ± 37.87 | 0.262 |
NIHSS | 6.00 (3.00–6.00) | 8.00 (5.25–14.50) | 0.155 |
TC | 4.21 ± 1.30 | 4.30 ± 0.78 | 0.808 |
TG | 1.60 ± 0.39 | 1.20 ± 0.49 | 0.038 |
HDLC | 1.11 ± 0.26 | 1.16 ± 0.32 | 0.688 |
LDLC | 2.11 (1.77–2.58) | 2.24 (2.02–3.14) | 0.601 |
VOLUME | 1.92 (0.43–12.05) | 32.79 (8.82–79.54) | 0.012 |
GRASPS | 71.67 ± 6.61 | 78.27 ± 8.53 | 0.047 |
SBP | 158.56 ± 11.04 | 160.00 ± 17.09 | 0.817 |
DBP | 87.22 ± 11.03 | 90.64 ± 14.28 | 0.527 |
FBG | 5.65 ± 0.82 | 7.35 ± 2.37 | 0.046 |
Hypertension | 0.244 | ||
 No | 0 (0.00) | 3 (13.64) |  |
 Yes | 9 (100.00) | 19 (86.36) |  |
Diabetes | 0.694 | ||
 No | 6 (66.67) | 13 (59.09) |  |
 Yes | 3 (33.33) | 9 (40.91) |  |
Coronary heart disease | 0.054 | ||
 No | 9 (100.00) | 15 (68.18) |  |
 Yes | 0 (0.00) | 7 (31.82) |  |
Stroke | 0.004 | ||
 No | 1 (11.11) | 15 (68.18) |  |
 Yes | 8 (88.89) | 7 (31.82) |  |
Gender | 0.505 | ||
 No | 4 (44.44) | 7 (31.82) |  |
 Yes | 5 (55.56) | 15 (68.18) |  |
Self-transferring | 0.062 | ||
 No | 7 (77.78) | 9 (40.91) |  |
 Yes | 2 (22.22) | 13 (59.09) |  |
ASPECTS | 0.259 | ||
 7 | 0 (0.00) | 1 (4.55) |  |
 8 | 0 (0.00) | 3 (13.64) |  |
 9 | 5 (55.56) | 5 (22.73) |  |
 10 | 4 (44.44) | 13 (59.09) |  |
HF | 0.849 | ||
 No | 8 (88.89) | 19 (86.36) |  |
 Yes | 1 (11.11) | 3 (13.64) |  |
Smoking | Â | ||
 No | 6 (66.67) | 9 (40.91) | 0.193 |
 Yes | 3 (33.33) | 13 (59.09) |  |